Responsiveness of the inhaled corticosteroid questionnaire (ICQ): a patient self-reported side effect scale Source: Eur Respir J 2006; 28: Suppl. 50, 208s Year: 2006
Reproducibility and patient acceptability of the inhaled corticosteroid questionnaire (ICQ): a patient self-reported side effect scale Source: Eur Respir J 2006; 28: Suppl. 50, 207s Year: 2006
Relationship between disease severity and inhaled corticosteroids questionnaire (ICQ) outcomes Source: Eur Respir J 2003; 22: Suppl. 45, 260s Year: 2003
The beliefs about medication questionnaire and adherence in users of inhaled corticosteroids Source: Eur Respir J 2006; 28: Suppl. 50, 572s Year: 2006
Asthma control in general practice with inhaled corticosteroids and long-acting B2-agonists administered as a fixed or free combination at stable dosage: the ALISE survey Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002
Personality influences the reporting of side effects of inhaled corticosteroids Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases Year: 2008
Does a visual analogue scale assist in the assessment of the use of nebulised bronchodilators for moderate/severe COPD patients? Source: Eur Respir J 2002; 20: Suppl. 38, 622s Year: 2002
Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010
Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021
Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017
An electronic patient decision aid comparing as-needed budesonide-formoterol combination to regular use of inhaled corticosteroid (ICS) in mild asthma: a rapid-cycle design study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021
The effect of smoking on severity of asthma and quality of life in patients treated with inhaled corticosteroids and long-acting b2-agonist (ICS/LABA) Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002
Satisfaction with inhaled asthma medication and patients quality of life Source: Eur Respir J 2004; 24: Suppl. 48, 285s Year: 2004
Feedback on inhaler use does not significantly improve inhaled corticosteroid adherence or clinical outcomes Source: Virtual Congress 2020 – Digital technologies in airway diseases Year: 2020
Measures to assess adherence to inhaled corticosteroids for asthma Source: Eur Respir J 2003; 22: Suppl. 45, 294s Year: 2003
The comparative assessment of quality of life in asthma patients treated with inhaled steroids Source: Eur Respir J 2003; 22: Suppl. 45, 282s Year: 2003
Clinical and economic impact of inhaled corticosteroid withdrawal in Spanish COPD patients treated with triple therapy Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
First line maintenance therapy for asthma: an observational study comparing inhaled corticosteroid monotherapy to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007